Pharmacodynamics Post-Hoc Analysis of Glucose Kinase Activator, Dorzagliatin (HMS5552) 12 Weeks Treatment in T2D Patients in China

2018 ADA Poster
Hua Medicine
Jan 01, 2018
721

Online link unavailable, presentationavailable upon request. (BD@huamedicine.com)

Focus Us
Copyright © 2020  Hua Medicine (Shanghai) Co., Ltd. 沪ICP备14036654号    beiantubiao.png 沪公网安备 31011502013809号
Search